Latest news with #IndogulfCropsciences


Economic Times
16 minutes ago
- Business
- Economic Times
Indogulf Cropsciences IPO to open on June 26; Price band set at Rs 105–111 per share
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel Indogulf Cropsciences has announced that its initial public offering (IPO) will open for subscription on Thursday, June 26, and close on Monday, June 30. The price band for the offer is fixed at Rs 105 to Rs 111 per equity share, each with a face value of Rs can bid for a minimum of 135 equity shares and in multiples IPO comprises a fresh issue of equity shares worth Rs 160 crore and an offer for sale (OFS) of up to 36,03,603 shares—including 15,40,960 shares by Om Prakash Aggarwal (HUF) and 20,62,643 shares by Sanjay Aggarwal (HUF).Indogulf plans to utilise Rs 65 crore from the fresh issue proceeds to meet working capital requirements, Rs 34.12 crore to repay or prepay certain outstanding borrowings, and Rs 14 crore towards capital expenditure for setting up a dry flowable (DF) manufacturing plant at Barwasni in Haryana's Sonipat district. The remaining funds will be used for general corporate in 1993, Indogulf Cropsciences operates across three primary business segments: crop protection, plant nutrients, and biologicals. The company caters to both retail and institutional customers and focuses on enhancing agricultural productivity. It is among the first few indigenous manufacturers of Pyrazosulfuron Ethyl technical in India, with a minimum purity of 97%, and began production in 2018. The company is also recognised as a Two-Star Export House and has exported products to over 34 company's clientele includes major domestic names such as Krishi Rasayan Exports, Parijat Industries, BR Agrotech, and Crystal Crop Protection. Its suppliers include Coromandel International, GSP Crop Science, and Chinese firms such as Dagro Chemical and Hubei Benxing Supply Chain currently operates four manufacturing facilities located in Jammu & Kashmir and Haryana. It also has two subsidiaries—Indogulf Cropsciences Australia Pty Ltd in Sydney and Abhiprakash Globus Private Limited in a strong domestic and international presence, the company operates across 22 Indian states and 3 Union Territories, supported by 6,916 active distributors, 192 institutional business partners, 17 stock depots, 6 sales and branch offices, and 143 overseas business partners spread across over 34 the company reported a revenue of Rs 552.23 crore in FY24, marginally up from Rs 549.66 crore in FY23. Profit after tax rose by 25.91% to Rs 28.23 crore in FY24, up from Rs 22.42 crore the previous year. For the nine months ended December 31, 2024, revenue stood at Rs 464.19 crore, with a net profit of Rs 21.68 crore. Systematix Corporate Services Limited is acting as the sole book-running lead manager to the issue, while Bigshare Services Private Limited is the registrar. The IPO will be conducted through a book-building process, with up to 50% of the net offer reserved for qualified institutional buyers (QIBs), at least 15% for non-institutional investors, and a minimum of 35% for retail individual on the price band, the total issue size is estimated at Rs 197.84 crore at the lower end and Rs 200 crore at the upper end.: Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times)


Time of India
19 minutes ago
- Business
- Time of India
Indogulf Cropsciences IPO to open on June 26; Price band set at Rs 105–111 per share
Indogulf Cropsciences has announced that its initial public offering (IPO) will open for subscription on Thursday, June 26, and close on Monday, June 30. The price band for the offer is fixed at Rs 105 to Rs 111 per equity share, each with a face value of Rs 10. Investors can bid for a minimum of 135 equity shares and in multiples thereafter. The IPO comprises a fresh issue of equity shares worth Rs 160 crore and an offer for sale (OFS) of up to 36,03,603 shares—including 15,40,960 shares by Om Prakash Aggarwal (HUF) and 20,62,643 shares by Sanjay Aggarwal (HUF). Indogulf plans to utilise Rs 65 crore from the fresh issue proceeds to meet working capital requirements, Rs 34.12 crore to repay or prepay certain outstanding borrowings, and Rs 14 crore towards capital expenditure for setting up a dry flowable (DF) manufacturing plant at Barwasni in Haryana's Sonipat district. The remaining funds will be used for general corporate purposes. Established in 1993, Indogulf Cropsciences operates across three primary business segments: crop protection, plant nutrients, and biologicals. The company caters to both retail and institutional customers and focuses on enhancing agricultural productivity. It is among the first few indigenous manufacturers of Pyrazosulfuron Ethyl technical in India, with a minimum purity of 97%, and began production in 2018. The company is also recognised as a Two-Star Export House and has exported products to over 34 countries. The company's clientele includes major domestic names such as Krishi Rasayan Exports, Parijat Industries, BR Agrotech, and Crystal Crop Protection. Its suppliers include Coromandel International, GSP Crop Science, and Chinese firms such as Dagro Chemical and Hubei Benxing Supply Chain Management. Indogulf currently operates four manufacturing facilities located in Jammu & Kashmir and Haryana. It also has two subsidiaries—Indogulf Cropsciences Australia Pty Ltd in Sydney and Abhiprakash Globus Private Limited in Delhi. With a strong domestic and international presence, the company operates across 22 Indian states and 3 Union Territories, supported by 6,916 active distributors, 192 institutional business partners, 17 stock depots, 6 sales and branch offices, and 143 overseas business partners spread across over 34 countries. Financially, the company reported a revenue of Rs 552.23 crore in FY24, marginally up from Rs 549.66 crore in FY23. Profit after tax rose by 25.91% to Rs 28.23 crore in FY24, up from Rs 22.42 crore the previous year. For the nine months ended December 31, 2024, revenue stood at Rs 464.19 crore, with a net profit of Rs 21.68 crore. Systematix Corporate Services Limited is acting as the sole book-running lead manager to the issue, while Bigshare Services Private Limited is the registrar. The IPO will be conducted through a book-building process, with up to 50% of the net offer reserved for qualified institutional buyers (QIBs), at least 15% for non-institutional investors, and a minimum of 35% for retail individual investors. Based on the price band, the total issue size is estimated at Rs 197.84 crore at the lower end and Rs 200 crore at the upper end. ( Disclaimer : Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times)


Mint
7 hours ago
- Business
- Mint
Indogulf Cropsciences IPO: Price band set at ₹105-111 per share; check issue details, key dates, more
Indogulf Cropsciences IPO price band has been fixed in the range of ₹ 105 to ₹ 111 per equity share of the face value of ₹ 10. The Indogulf Cropsciences IPO date of subscription is scheduled for Thursday, June 26 and will close on Monday, June 30. The allocation to anchor investors for the Indogulf Cropsciences IPO is scheduled to take place on Wednesday, June 25. The floor price is 10.50 times the face value of the equity shares and the cap price is 11.10 times the face value of the equity shares. The Indogulf Cropsciences IPO lot size is 135 equity shares and in multiples of 135 equity shares thereafter. Indogulf Cropsciences IPO has reserved not more than 50% of the shares in the public issue for qualified institutional buyers (QIB), not less than 15% for non-institutional Institutional Investors (NII), and not less than 35% of the offer is reserved for retail investors. Tentatively, Indogulf Cropsciences IPO basis of allotment of shares will be finalised on Tuesday, July 1 and the company will initiate refunds on Wednesday, July 2, while the shares will be credited to the demat account of allottees on the same day following refund. Indogulf Cropsciences share price is likely to be listed on BSE and NSE on Thursday, July 3. Indogulf Cropsciences Limited specializes in the production of crop protection products, plant nutrients, and biological solutions in India. In 2019, the company produced Spiromesifen technical with a purity level of 96.5% and became one of the pioneering local producers of Pyrazosulfuron Ethyl technical with 97% purity in India. The company has four manufacturing plants located in Samba (Jammu & Kashmir) and Nathupur (Haryana), spanning around twenty acres, which includes two sites in Nathupur and one in Barwasni, Haryana. Indogulf has a distribution network that extends to 22 states and 3 Union Territories across India, supported by 169 business partners, 5,772 distributors, and 129 partners in 34 countries around the world. As per the red herring prospectus, the company's listed peers are Aries Agro Ltd (with a P/E of 17.47), Basant Agro Tech India Ltd (with a P/E of 44.58), Best Agrolife Ltd (with a P/E of 12.23), Bhagiradha Chemicals & Industries Ltd (with a P/E of 101.81), Heranba Industries Ltd (with a P/E of 35.34), India Pesticides Ltd (with a P/E of 41.62), and Dharmaj Crop Guard Ltd (with a P/E of 18.02). Indogulf Cropsciences IPO comprises a fresh issue of ₹ 160 crore, and an offer-for-sale (OFS) of 36,03,603 equity shares by the promoter group selling shareholder. Indogulf Cropsciences IPO aims to allocate the net proceeds from the issue for various purposes, including meeting working capital needs, repaying or prepaying debts, funding capital expenditures for the company, or establishing an in-house dry flowable (DF) facility in Haryana, as well as for general corporate activities. Systematix Corporate Services Limited serves as the book-running lead manager for the Indogulf Cropsciences IPO, whereas Bigshare Services Pvt Ltd acts as the registrar for this issue. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.